John A Carter

EPI-Q, Inc
1315 West 22nd Street, Suite 410
Corporate Settings
Oak Brook, IL
USA
60523
Email: john.carter@epi-q.com

Papers:
224 Subdermal Buprenorphine Implants Improve Societal Outcomes and Patient Morbidity and Mortality Relative to Sublingual Buprenorphine: Results of a Markov Model